Adami, Maria-Evangelia
Eugen-Olsen, Jesper
Giamarellos-Bourboulis, Evangelos J.
Article History
Received: 9 May 2024
Accepted: 28 May 2024
First Online: 5 June 2024
Declarations
:
: Not applicable.
: Not applicable.
: EJGΒ has received honoraria from Abbott Products Operations, bioMérieux, Brahms GmbH, GSK, InflaRx GmbH and Sobi; independent educational grants from Abbott Products Operations, AbbVie, bioMérieux Inc, InCyte, Johnson & Johnson, MSD, UCD and Sobi; and funding from the Horizon 2020 Marie Skłodowska-Curie International Training Network “the European Sepsis Academy” (granted to the National and Kapodistrian University of Athens), the Horizon 2020 European Grants ImmunoSep and RISC in COVID and the Horizon Health grant EPIC-CROWN-2 and POINT (granted to the Hellenic Institute for the Study of Sepsis). JE-O is a co-founder, shareholder, and CSO of ViroGates, Denmark, and named inventor on patents on suPAR owned by Copenhagen University Hospital Hvidovre, Denmark. The other authors do not disclose any conflict of interest.